Legacy Healthcare is developping safer drugs for the treatment of autoimmune and inflammatory diseases in fragile patients
Legacy Healthcare is developping safer drugs for the treatment of autoimmune and inflammatory diseases in fragile patients
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 29, 2022 | Grant | Fr2.60M | 1 |
![]() |
— | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
![]() |
Yes | Grant |